RANKL-induced DC-STAMP Is Essential for Osteoclastogenesis by Kukita, Toshio et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
J. Exp. Med. 
 
©
 
 The Rockefeller University Press • 0022-1007/2004/10/941/6 $8.00
Volume 200, Number 7, October 4, 2004 941–946
http://www.jem.org/cgi/doi/10.1084/jem.20040518
 
Brief Deﬁnitive Report
 
941
 
RANKL-induced DC-STAMP Is Essential 
for Osteoclastogenesis
 
Toshio Kukita,
 
1
 
 Naohisa Wada,
 
1
 
 Akiko Kukita,
 
2
 
 Takashi Kakimoto,
 
2 
 
Ferry Sandra,
 
1
 
 Kazuko Toh,
 
1
 
 Kengo Nagata,
 
1
 
 Tadahiko Iijima,
 
1
 
 
Madoka Horiuchi,
 
3,4
 
 Hiromi Matsusaki,
 
4
 
 Kunio Hieshima,
 
5 
 
Osamu Yoshie,
 
5 
 
and Hisayuki Nomiyama
 
3
 
1
 
Division of Oral Biological Sciences, Faculty of Dental Science, Kyushu University, Fukuoka 812-8582, Japan
 
2
 
Department of Microbiology, Saga Medical School, Saga 849-8501, Japan
 
3
 
Department of Molecular Enzymology, Kumamoto University Graduate School of Medical Sciences, Kumamoto 
860-8556, Japan
 
4
 
Faculty of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, Kumamoto 862-8502, Japan
 
5
 
Department of Microbiology, Solution Oriented Research for Science and Technology, Kinki University School of 
Medicine, Osaka-Sayama, Osaka 589-8511, Japan
 
Abstract
 
Osteoclasts are bone-resorbing, multinucleated giant cells that are essential for bone remodeling
and are formed through cell fusion of mononuclear precursor cells. Although receptor activator
of nuclear factor–
 
 
 
B ligand (RANKL) has been demonstrated to be an important osteoclasto-
genic cytokine, the cell surface molecules involved in osteoclastogenesis are mostly unknown.
Here, we report that the seven-transmembrane receptor-like molecule, dendritic cell–specific
transmembrane protein (DC-STAMP) is involved in osteoclastogenesis. Expression of DC-
STAMP is rapidly induced in osteoclast precursor cells by RANKL and other osteoclastogenic
stimulations. Targeted inhibition of DC-STAMP by small interfering RNAs and specific antibody
markedly suppressed the formation of multinucleated osteoclast-like cells. Overexpression of
DC-STAMP enhanced osteoclastogenesis in the presence of RANKL. Furthermore, DC-STAMP
directly induced the expression of the osteoclast marker tartrate-resistant acid phosphatase. These
data demonstrate for the first time that DC-STAMP has an essential role in osteoclastogenesis.
Key words: osteoclast • cell fusion • adhesion • seven-transmembrane receptor • TRAP
 
Introduction
 
Osteoclasts are the multinucleated cells (MNCs) generated
from mononuclear osteoclast precursor cells of the mono-
cyte/macrophage lineage upon osteoclastogenic stimula-
tions (1–4). Receptor activator of NF-
 
 
 
B ligand (RANKL)
is now known as an essential cytokine for the osteoclasto-
genesis, and downstream signaling events mediated by its
receptor RANK have been studied extensively (3, 4). How-
ever, the molecular mechanisms regulating the polykaryon
formation still remain mostly unknown, although several
cell surface molecules are considered to play a role (5–8).
From a mouse macrophage-like cell line, RAW264, we
have recently isolated an osteoclast precursor clone termed
RAW-D, which efficiently differentiates into osteoclast-
like MNCs upon treatment with RANKL, and a control
clone termed RAW-N, which does not differentiate into
MNCs even in the presence of RANKL (9). To identify
molecules involved in the osteoclastogenesis, we compared
the profiles of mRNA expression between RAW-D and
RAW-N by using a cDNA subtraction technique and
identified mRNA species that were highly expressed in
RAW-D but not in RAW-N upon stimulation with
RANKL (unpublished data). Dendritic cell–specific trans-
membrane protein (DC-STAMP; reference 10), also known
as IL-4–induced gene (FIND; reference 11), is among the
identified genes markedly induced in RANKL-stimulated
RAW-D. DC-STAMP was originally isolated from a
cDNA library of human monocyte–derived dendritic cells
and encodes a protein with putative seven-transmembrane
 
The online version of this article contains supplemental material.
Address correspondence to Hisayuki Nomiyama, Dept. of Molecular
Enzymology, Kumamoto University Graduate School of Medical Sci-
ences, Kumamoto 860-8556, Japan. Phone: 81-96-373-5065; Fax: 81-
96-373-5066; email: nomiyama@gpo.kumamoto-u.ac.jp 
DC-STAMP Is a Novel Regulator of Osteoclastogenesis
 
942
domains. However, it has no strong sequence homology
with any other proteins and little is known about its role in
the dendritic cell function. Here, we show for the first time
that DC-STAMP is critically involved in the MNC forma-
tion and tartrate-resistant acid phosphatase (TRAP) gene
expression in RAW-D cells and mouse BM osteoclast pre-
cursor cells.
 
Materials and Methods
 
Cell Culture. 
 
RAW-D and RAW-N cells were cultured as
described previously (9). These cells were stimulated with 20 ng/
ml of soluble human RANKL (PeproTech) and 1 ng/ml of hu-
man TNF-
 
 
 
 (PeproTech). Mouse BM cells were cultured in the
presence of 10
 
 
 
8
 
 M 1
 
 
 
,25 dihydroxyvitamin D
 
3
 
 (1
 
 
 
,25(OH)
 
2
 
D
 
3
 
)
to form osteoclast-like MNCs as described previously (12). Isola-
tion of osteoclasts and pit formation assays were performed as de-
scribed previously using osteoclast-like cells formed in the rat BM
culture system (13). Mouse L1.2 pre–B cell line was provided by
E. Butcher (Stanford University, Stanford, CA).
 
Northern Blot Analysis and RT-PCR.
 
For Northern blot anal-
ysis, total cellular RNAs were separated, blotted onto membrane
filters, and hybridized with cRNA probes. The probes were la-
beled and detected with DIG RNA labeling and detection kit
(Roche Diagnostics). RT-PCR was performed as described pre-
viously (14). Nucleotide sequences of PCR primers are shown in
Table S1 (available at http://www.jem.org/cgi/content/full/
jem.20040518/DC1).
 
siRNA Preparation and Transfection. 
 
Small interfering RNA
(siRNA) oligonucleotides were prepared and transfected using
Silencer siRNA construction and transfection kits (Ambion). The
sequences of oligonucleotides synthesized for templates are shown
in Table S1. After transfection, cells were cultured with RANKL
and TNF-
 
 
 
 for 3 d.
 
Expression Vectors for DC-STAMP and DC-STAMP
 
 
 
T7.
 
DC-STAMP and DC-STAMP
 
 
 
T7 cDNAs were amplified by
RT-PCR and inserted into pCI-neo (Promega) or pEGFP-N1
expression vector (CLONTECH Laboratories, Inc.). The PCR
primers used are shown in Table S1. For transient expression of
DC-STAMP and DC-STAMP
 
 
 
T7, 3 
 
 
 
 10
 
6 
 
RAW-D cells were
transfected with 3 
 
 
 
g of expression vectors by using the DEAE-
dextran method. Cells were cultured for 3 d without or with
RANKL and TNF-
 
 
 
. For stable expression of DC-STAMP and
DC-STAMP
 
 
 
T7, we used a retrovirus expression vector pMX-
IRES-EGFP II (a gift from T. Kitamura, Tokyo University, To-
kyo, Japan). The cDNAs were ligated into the SalI–NotI sites of
the vector. Production of recombinant retroviruses and infection
of mouse L1.2 cells with the recombinant viruses were performed
as described previously (15).
 
Preparation of Rabbit Anti–DC-STAMP Antibody. 
 
A syn-
thetic DC-STAMP peptide corresponding to the fourth extracel-
lular domain (SLPGLEVHLKLRGE; Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20040518/DC1) was conju-
gated to KLH and immunized to rabbits using a standard proto-
col. The antibody was affinity purified from pooled antiserum.
 
Immunostaining.
 
10-
 
 
 
m cryosections of the mandibular tissue
were prepared from newborn mice. Isolated osteoclasts or stimu-
lated RAW-D cells were fixed and stained with 4 
 
 
 
g/ml of anti–
DC-STAMP antibody. Immunoreactivity was detected with
ABC kit (Vector Laboratories).
 
Paraformaldehyde Fixation. 
 
Mouse L1.2 cells (2 
 
 
 
 10
 
6
 
) stably
expressing DC-STAMP or DC-STAMP
 
 
 
T7 were suspended in
4% paraformaldehyde-PBS and incubated at room temperature
for 20 min. After washing, cells were resuspended in 1 ml of
 
 
 
MEM containing 10% FBS.
 
Statistical Analysis. 
 
Each data point represents mean 
 
 
 
 SEM
from quadruplicate cultures. Statistical significance was deter-
mined using Student’s 
 
t
 
 test or post–analysis of variance test.
 
Online Supplemental Material. 
 
Table S1 contains oligonucle-
otide sequences. Fig. S1 depicts the alignment of amino acid se-
quences of mouse DC-STAMP and DC-STAMP
 
 
 
T7 with that of
human DC-STAMP. Fig. S2 shows surface immunostaining of dif-
ferentiated RAW-D cells with anti–DC-STAMP. Fig. S3 depicts
localization of the COOH terminals of DC-STAMP and DC-
STAMP
 
 
 
T7 tagged with EGFP. Fig. S4 shows enhanced poly-
karyon formation in RANKL-stimulated RAW-D cells transfected
with DC-STAMP expression vector. Fig. S5 shows how overex-
pression of DC-STAMP-EGFP induces TRAP positive cells in
RAW-D cells. Fig. S6 depicts the postulated signaling pathways
for osteoclastogenesis. Online supplemental material is available at
http://www.jem.org/cgi/content/full/jem.20040518/DC1.
 
Results and Discussion
 
Based on the sequence of a cDNA fragment identified
through subtraction between RANKL-stimulated RAW-D
and RAW-N, we prepared specific primers for mouse DC-
STAMP and performed RT-PCR using RANKL-stimu-
lated RAW-D. We consistently observed two bands on the
gel (see Fig. 1 C). We isolated both cDNAs by RT-PCR
using primers based on the cDNA sequence of mouse DC-
STAMP reported in the mouse full-length cDNA sequenc-
ing project (GenBank/EMBL/DDBJ accession no. AK014697).
One cDNA clone was found to encode the mouse full-
length DC-STAMP, which showed 74% identity to the
human counterpart, whereas the other, apparently derived
from an alternative splicing, encoded a protein lacking the
putative seven-transmembrane domain, which we desig-
nated DC-STAMP
 
 
 
T7 (Fig. 1 A and Fig. S1).
By Northern blot analysis, we examined the expression
of DC-STAMP mRNA in RAW-N and RAW-D cells
treated without or with RANKL 
 
 
 
 TNF-
 
 
 
. TNF-
 
 
 
 was
included because it enhances RANKL-induced osteoclas-
togenesis (16). As shown in Fig. 1 B, treatment with
RANKL 
 
 
 
 TNF-
 
 
 
 for 3 d strongly induced DC-STAMP
mRNA (
 
 
 
2 kb in size) in RAW-D but not in RAW-N.
The formation of osteoclast-like MNCs in RAW-D was
also at its peak on the third day of culture. Even though
MIP-1
 
 
 
/CCL3 was known to enhance osteoclastogenesis
(17, 18), it did not further up-regulate DC-STAMP expres-
sion in RAW-D cells. By semi-quantitative RT-PCR anal-
ysis, both DC-STAMP and DC-STAMP
 
 
 
T7 mRNAs were
induced in RAW-D cells within 16 h after stimulation with
RANKL 
 
 
 
 TNF-
 
 
 
 and further up-regulated during the pe-
riod of 72 h (Fig. 1 C). It was also evident that DC-STAMP
mRNA was much more abundant than DC-STAMP
 
 
 
T7
mRNA. Furthermore, DC-STAMP and DC-STAMP
 
 
 
T7
were induced well ahead of the osteoclast marker enzymes
TRAP and cathepsin K (Fig. 1 C). We also confirmed
strong induction of DC-STAMP and DC-STAMP
 
 
 
T7 in
mouse BM cultures treated with a potent osteoclastogenesis 
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inducer 1
 
 
 
,25(OH)
 
2
 
D
 
3
 
 (Fig. 1 D and reference 19). In this
system, the formation of osteoclasts reached at its peak
on the sixth day of culture. Again, DC-STAMP mRNA
was dominant over DC-STAMP
 
 
 
T7 mRNA. Collectively,
these data clearly demonstrated that both DC-STAMP and
DC-STAMP
 
 
 
T7 are strongly induced in RAW-D and mouse
BM culture upon osteoclastogenic stimulations. Consistent
with our findings, Rho et al. reported previously that osteo-
clasts expressed DC-STAMP mRNA at levels much higher
than dendritic cells (20).
Next, we performed immunological staining of DC-
STAMP proteins in RANKL-stimulated RAW-D cells and
osteoclasts derived from mouse BM. We prepared affinity
purified anti–DC-STAMP from pooled sera of rabbits
immunized with a polypeptide common to both DC-
STAMP and DC-STAMP
 
 
 
T7. By immunoblotting, we
confirmed that anti–DC-STAMP specifically reacted with
a broad band of 
 
 
 
50 kD, probably the mixture of DC-
STAMP (54 kD) and its 
 
 
 
T7 variant (48 kD), in the pro-
tein extract of RANKL-stimulated RAW-D cells (unpub-
lished data). As shown in Fig. 2 A, anti–DC-STAMP
stained osteoclast-like MNCs and some mononuclear cells
in RAW-D cells stimulated with RANKL 
 
 
 
 TNF-
 
 
 
.
Anti–DC-STAMP also stained the basolateral membrane of
osteoclasts in the cryosections of mouse bone tissues (Fig. 2
B), osteoclasts isolated from tibiae of newborn mice (Fig. 2
C), and rat osteoclasts (not depicted). Furthermore, living
RANKL-stimulated RAW-D cells, but not RAW-N cells,
strongly reacted with anti–DC-STAMP (Fig. S2, available
at http://www.jem.org/cgi/content/full/jem.20040518/DC1).
These results clearly demonstrated that DC-STAMP is highly
expressed on the surface of osteoclasts.
The COOH terminal of human DC-STAMP was re-
ported to be located within the cytoplasm of dendritic
cells (10). Alternately, the COOH terminal of the DC-
STAMP
 
 
 
T7 lacking the seven-transmembrane domain
might be extracellular. To test this hypothesis, we
Figure 1. Induction of DC-STAMP and its splicing variant DC-
STAMP T7 in osteoclastogenesis. (A) Structures of DC-STAMP and
DC-STAMP T7. Noncoding and coding sequences are shown in un-
shaded and shaded boxes, respectively. PCR primers used in C and D are
indicated by arrows. Schematic protein structures are shown below the gene.
Shaded regions indicate the putative transmembrane domains. (B) Northern
blot analysis for induction of DC-STAMP and DC-STAMP T7 in
RAW-D cells. RAW-D and RAW-N cells were stimulated for 72 h as
indicated. c, control; N, RAW-N; D, RAW-D. (C) RT-PCR analysis
on the time course of DC-STAMP and DC-STAMP T7 induction in
RAW-D cells. RAW-D cells were stimulated with RANKL   TNF- 
for indicated periods of time. Expression of DC-STAMP, DC-
STAMP T7, and osteoclast marker genes (cathepsin K and TRAP) was
analyzed. (D) RT-PCR analysis on the time course of DC-STAMP and
DC-STAMP T7 induction in mouse BM cells. Mouse BM cells were
stimulated with 1 ,25(OH)2D3. Expression of DC-STAMP and DC-
STAMP T7 was analyzed. The GenBank/EMBL/DDBJ accession nos.
of mouse DC-STAMP and DC-STAMP T7 are AB109560 and AB109561,
respectively.
Figure 2. Immunological staining of DC-STAMP in osteoclasts. Cells
and tissues were stained with anti–DC-STAMP (left) or control preimmune
IgG (right). (A) RAW-D cells stimulated with RANKL   TNF-  for
3 d. Nuclei were visualized by staining with hematoxylin. DC-STAMP
positive osteoclast-like MNCs and mononuclear cells are indicated by arrows
and arrowheads, respectively. (B) Osteoclasts present in the mandibular
tissue of newborn mice. (C) Osteoclasts isolated from the tibia of new-
born mice. OC, osteoclast. Bars: 25  m (A), 10  m (B), and 20  m (C). 
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generated plasmids encoding DC-STAMP and DC-
STAMP
 
 
 
T7 tagged at their COOH terminals with en-
hanced GFP (EGFP) and transfected these plasmids into
HEK293T cells. We confirmed the expression of DC-
STAMP proteins in transfected HEK293T cells by immu-
nocytochemical staining with anti–DC-STAMP (Fig. S3
A, available at http://www.jem.org/cgi/content/full/jem.
20040518/DC1). As expected, we observed that the EGFP-
tagged COOH terminals of DC-STAMP and DC-STAMP
 
 
 
T7
are indeed cytoplasmic and extracellular, respectively (Fig.
S3 B).
To investigate the role of DC-STAMP in osteoclastogen-
esis, we first performed experiments using siRNAs; one
siRNA (no. 135) was designed to target the seven-trans-
membrane domain, which is present only in DC-STAMP,
and the other (no. 6) was designed to suppress the expres-
sion of both DC-STAMP and DC-STAMP
 
 
 
T7. A mutant
siRNA with two nucleotide changes in the middle of the
sequence was also synthesized for each siRNA. RAW-D
cells were transfected with these siRNAs and cultured for 3
d in the presence of RANKL 
 
 
 
 TNF-
 
 
 
. After that, TRAP
positive MNCs were counted. As shown in Fig. 3 A, both
nos. 135 and 6 siRNAs dose dependently suppressed the
formation of TRAP positive MNCs in RAW-D cells stim-
ulated with RANKL 
 
 
 
 TNF-
 
 
 
, whereas mutant siRNAs
were much less effective. We observed no significant differ-
ence between the inhibitory effects of nos. 135 and 6 siRNAs.
This was most probably due to the dominant expression
of DC-STAMP over DC-STAMP
 
 
 
T7. By RT-PCR, we
confirmed that no. 6 siRNA efficiently inhibited the ex-
pression of both DC-STAMP and DC-STAMP
 
 
 
T7 (Fig. 3
A, right). These results strongly suggested that DC-STAMP
plays an essential role in osteoclastogenesis of RAW-D cells.
To further investigate the role of DC-STAMP in osteo-
clastogenesis, next we examined the effect of anti–DC-
STAMP. As shown in Fig. 3 B, anti–DC-STAMP signifi-
cantly reduced the formation of TRAP positive MNCs in
RAW-D cells stimulated for 3 d with RANKL 
 
 
 
 TNF-
 
 
 
.
Anti–DC-STAMP also significantly suppressed osteoclasto-
genesis in 1
 
 
 
,25(OH)
 
2
 
D
 
3-stimulated mouse BM cultures
(Fig. 3 C). We also examined the effects of anti–DC-
STAMP on the pit formation by osteoclasts generated from
rat BM cultures. As shown in Fig. 3 D, anti–DC-STAMP
significantly suppressed the formation of resorption pits on
dentin slices in contrast to control IgG. These results fur-
ther demonstrated that DC-STAMP is critically involved
in the generation and function of osteoclasts.
Next, we examined forced expression of DC-STAMP
and DC-STAMP T7 in RAW-D cells. The expression
vectors were transiently transfected into RAW-D cells. The
transfection efficiency was  10%. As shown in Fig. 4 A,
forced expression of either DC-STAMP or DC-STAMP T7
in RAW-D cells did not induce the formation of TRAP
positive MNCs but significantly enhanced their formation
upon further stimulation with RANKL. Enhanced fusion
process was evident from the increased multinuclearity of
TRAP positive MNCs (Fig. S4, available at http://www.
jem.org/cgi/content/full/jem.20040518/DC1). Consider-
ing the relatively low transfection efficiency of RAW-D
cells, the enhancing effects of DC-STAMP proteins on the
formation of TRAP positive MNCs might be quite high.
We confirmed that anti–DC-STAMP effectively blocked
the formation of TRAP positive MNCs in transfected
RAW-D cells (unpublished data).
To further investigate how the forced expression of DC-
STAMP proteins enhanced the formation of TRAP posi-
tive MNCs in RANKL-stimulated RAW-D cells, we tran-
siently transfected RAW-D cells with an expression vector
encoding DC-STAMP fused with EGFP and cultured the
cells without any differentiation stimuli. We consistently
observed that mononuclear cells in close contact with GFP
positive MNCs were TRAP positive (Fig. S5, available at
Figure 3. Inhibition of osteo-
clastogenesis by DC-STAMP
siRNAs and by anti–DC-STAMP.
(A) Effects of the siRNAs on the formation of osteoclast-like TRAP positive MNCs in RAW-D
cells stimulated with RANKL and TNF-  for 3 d. Specific reduction of DC-STAMP mRNA
and DC-STAMP T7mRNA by #6 siRNA was evaluated by RT-PCR (right). *, P   0.05; **,
P   0.01; ***, P   0.001. (B) Inhibition of osteoclast-like TRAP positive MNC formation
in RAW-D cells by anti–DC-STAMP. RAW-D cells were treated with RANKL and TNF- 
for 3 d without or with indicated concentrations of anti–DC-STAMP. **, P   0.01; ***, P  
0.001. IgG, control IgG (20  g/ml). (C) Inhibition of osteoclastogenesis in mouse BM cells by
anti–DC-STAMP. BM cells were cultured in the presence of 1 ,25(OH)2D3 for 6 d without or
with indicated concentrations of anti–DC-STAMP. *, P   0.05; **, P   0.01. (D) Anti–DC-
STAMP inhibits osteoclast function. Rat osteoclast-like cells formed in BM cultures were
seeded on dentin slices and cultured for 3 d in the presence of 10  g/ml of control IgG or anti–
DC-STAMP. *, P   0.05.Kukita et al. Brief Definitive Report 945
http://www.jem.org/cgi/content/full/jem.20040518/DC1).
In contrast, forced expression of DC-STAMP–EGFP did
not induce TRAP positive cells in RAW-N cells. Collec-
tively, these results suggested that DC-STAMP on the cell
surface are capable of inducing TRAP expression in neigh-
boring RAW-D cells probably via interacting with a puta-
tive DC-STAMP ligand on the cell surface. Furthermore,
RAW-N cells may also be defective in the expression of
this DC-STAMP ligand.
To further investigate whether DC-STAMP interacts
with a membrane-bound ligand expressed on RAW-D cells,
we generated mouse L1.2 preB cells stably expressing DC-
STAMP or DC-STAMP T7 by using a retrovirus vector
polycistronically encoding EGFP, and tested whether
these cells were able to adhere and/or fuse with RAW-D
cells. When L1.2 cells expressing DC-STAMP or DC-
STAMP T7 were cocultured with RAW-D cells without
any differentiation stimuli, no firm adhesion strong enough
to resist gentle washing or cell fusion was observed un-
der fluorescence microscopy (unpublished data). However,
marked induction of TRAP positive mononuclear cells was
observed in RAW-D cells (Fig. 4 B). Both DC-STAMP and
DC-STAMP T7 were similarly effective in inducing TRAP
expression in RAW-D cells. To eliminate a possible involve-
ment of cytokines secreted by L1.2 cells, the cells were pre-
fixed with paraformaldehyde and added to RAW-D cells.
Fixed DC-STAMP–expressing L1.2 cells still significantly
induced TRAP positive mononuclear cells in RAW-D,
whereas fixed DC-STAMP T7–expressing L1.2 cells failed
to do so (Fig. 4 B). This might be due to structural instability
of DC-STAMP T7 upon fixation. We also confirmed that
anti–DC-STAMP effectively suppressed induction of TRAP
in RAW-D cells by fixed DC-STAMP–expressing L1.2 cells
(unpublished data). These data supported that a putative DC-
STAMP ligand expressed on the cell surface of RAW-D me-
diates induction of TRAP expression upon interaction with
DC-STAMP proteins, although additional cell surface mole-
cules induced and/or activated by RANKL may be required
for the efficient formation of MNCs.
Cell surface molecules such as macrophage fusion recep-
tor, CD47, and CD44 have been demonstrated to be in-
volved in the osteoclastogenesis (5–8). Compared with
these molecules, DC-STAMP has several unique features.
First, DC-STAMP has a distinct structure that these pro-
teins do not have. DC-STAMP has been predicted to have
a seven-transmembrane domain structure similar to the
members of the G protein–coupled receptor (GPCR) su-
perfamily. Does DC-STAMP function as a cell adhesion
molecule in osteoclastogenesis? Among the GPCR super-
family, two chemokine receptors are known to function as
direct cell adhesion molecules through interactions with
their transmembrane-type ligands (14, 21). Given such ex-
amples, DC-STAMP may also function as a direct cell ad-
hesion molecule by interacting with its putative mem-
brane-bound ligand. The osteoclast fusion process may be
initiated upon this adhesive interaction, which may be
too weak to be seen in the present experimental condi-
tions. Second, TRAP induction in RAW-D cells by DC-
STAMP and DC-STAMP T7 suggests signaling through
the putative cell surface ligand of DC-STAMP. Third,
DC-STAMP and DC-STAMP T7 have similar activities
so far, indicating that the seven-transmembrane domain
and the intracellular COOH terminus may not be essential
for its function. The splicing variant identical with DC-
STAMP T7 has not been identified in human dendritic
cells, but a larger deletion mutant that also lacks the seven-
transmembrane domain has been reported previously (22).
Because the domains in GPCRs, which are critical for the
interaction with the G proteins, are localized at the second
and third cytoplasmic loops and the COOH terminal (23),
DC-STAMP T7 may not be properly associated with
the G proteins. Thus, DC-STAMP and DC-STAMP T7
may behave differently upon binding with putative DC-
STAMP ligand. It remains to be seen whether DC-STAMP
 T7 has any function different from DC-STAMP.
In conclusion, we have demonstrated for the first time
that DC-STAMP plays an important role in the osteoclas-
togenesis (Fig. S6, available at http://www.jem.org/cgi/
content/full/jem.20040518/DC1). DC-STAMP induces
TRAP expression in osteoclast precursors via its putative
cell surface ligand. However, aside from DC-STAMP and
its cell surface ligand, other cell surface molecules may also
Figure 4. Promotion of osteoclastogenesis
in RAW-D cells by DC-STAMP and DC-
STAMP T7. (A) Transfection of RAW-D
cells with control, DC-STAMP, or DC-
STAMP T7 expression vectors. Cells were
treated without or with RANKL   TNF- 
for 3 d. Osteoclast-like TRAP positive
MNCs were counted. **, P   0.01; ***, P  
0.001. (B) Induction of TRAP in RAW-D
cells by coculture with mouse pre–B L1.2
cells stably expressing DC-STAMP or DC-
STAMP T7. RAW-D cells were cocul-
tured with live (left) or fixed (right) L1.2
cells or L1.2 cells stably expressing DC-
STAMP or DC-STAMP T7 in the absence
of osteoclastogenic factors for 3 d. Osteoclast-
like TRAP positive MNCs were counted.
**, P   0.01.DC-STAMP Is a Novel Regulator of Osteoclastogenesis 946
be needed to initiate efficient MNC formation. Such cell
surface factors may be induced and/or activated by signal-
ing via DC-STAMP and/or its putative ligand. Thus, iden-
tification of DC-STAMP ligand will further elucidate the
molecular mechanisms of the osteoclastogenesis.
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